Kumiko Ogawa

Kumiko Ogawa

Auto-generated profile, based on publicly available information

Kumiko Ogawa

Division of Pathology National Institute of Health Sciences Kawasaki‐ku Kawasaki Japan

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2012 in Cancer Science
Verified
Journal Article
Closed access
PDF file
KOKumiko Ogawa
Kumiko Ogawa
PPPornsiri Pitchakarn
Pornsiri Pitchakarn
SSShugo Suzuki
Shugo Suzuki
TCTeera Chewonarin
Teera Chewonarin
MTMingXi Tang
MingXi Tang
TSTomoyuki Shirai
Tomoyuki Shirai

4 January 2014 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
SOSaeko Onami
Saeko Onami
YCYoung-Man Cho
Young-Man Cho
TTTakeshi Toyoda
Takeshi Toyoda
YMYasuko Mizuta
Yasuko Mizuta
MYMidori Yoshida
Midori Yoshida
KOKumiko Ogawa
Kumiko Ogawa

30 July 2013 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
TTTakeshi Toyoda
Takeshi Toyoda
Tetsuya TsukamotoTetsuya Tsukamoto
Tetsuya Tsukamoto
MYMasami Yamamoto
Masami Yamamoto
HBHisayo Ban
Hisayo Ban
NSNoriko Saito
Noriko Saito
MTMasae Tatematsu
Masae Tatematsu
Background: Helicobacter pylori (H. pylori) infection and excessive salt intake are known as important risk factors for stomach cancer in humans. However, interactions of these two factors with gene expression profiles during gastric carcinogenesis remain unclear. In the present study, we investigated the global gene expression associated with stomach carcinogenesis and prognosis of human gastric cancer using a mouse model. Methods: To find candidate genes involved in stomach carcinogenesis, we firstly constructed a carcinogen-induced mouse gastric tumor model combined with H. pylori infection and high-salt diet. C57BL/6J mice were given N-methyl-N-nitrosourea in their drinking water and sacrificed after 40 weeks. Animals of a combination group were inoculated with H. pylori and fed a high-salt diet. Gene expression profiles in glandular stomach of the mice were investigated by oligonucleotide microarray. Second, we examined an availability of the candidate gene as prognostic factor for human patients. Immunohistochemical analysis of CD177, one of the up-regulated genes, was performed in human advanced gastric cancer specimens to evaluate the association with prognosis. Results: The multiplicity of gastric tumor in carcinogen-treated mice was significantly increased by combination of H. pylori infection and high-salt diet. In the microarray analysis, 35 and 31 more than two-fold up-regulated and down-regulated genes, respectively, were detected in the H. pylori-infection and high-salt diet combined group compared with the other groups. Quantitative RT-PCR confirmed significant over-expression of two candidate genes including Cd177 and Reg3g. On immunohistochemical analysis of CD177 in human advanced gastric cancer specimens, over-expression was evident in 33 (60.0%) of 55 cases, significantly correlating with a favorable prognosis (P = 0.0294). Multivariate analysis including clinicopathological factors as covariates revealed high expression of CD177 to be an independent prognostic factor for overall survival. Conclusions: These results suggest that our mouse model combined with H. pylori infection and high-salt diet is useful for gene expression profiling in gastric carcinogenesis, providing evidence that CD177 is a novel prognostic factor for stomach cancer. This is the first report showing a prognostic correlation between CD177 expression and solid tumor behavior.

Verified
Journal Article
Open access
PDF file
CSChristian Strupp
Christian Strupp
MCMarco Corvaro
Marco Corvaro
SCSamuel M. Cohen
Samuel M. Cohen
JCJ. Christopher Corton
J. Christopher Corton
KOKumiko Ogawa
Kumiko Ogawa
MJMiriam Naomi Jacobs
Miriam Naomi Jacobs
In contrast to genotoxic carcinogens, there are currently no internationally agreed upon regulatory tools for identifying non-genotoxic carcinogens of human relevance. The rodent cancer bioassay is only used in certain regulatory sectors and is criticized for its limited predictive power for human cancer risk. Cancer is due to genetic errors occurring in single cells. The risk of cancer is higher when there is an increase in the number of errors per replication (genotoxic agents) or in the number of replications (cell proliferation-inducing agents). The default regulatory approach for genotoxic agents whereby no threshold is set is reasonably conservative. However, non-genotoxic carcinogens cannot be regulated in the same way since increased cell proliferation has a clear threshold. An integrated approach for the testing and assessment (IATA) of non-genotoxic carcinogens is under development at the OECD, considering learnings from the regulatory assessment of data-rich substances such as agrochemicals. The aim is to achieve an endorsed IATA that predicts human cancer better than the rodent cancer bioassay, using methodologies that equally or better protect human health and are superior from the view of animal welfare/efficiency. This paper describes the technical opportunities available to assess cell proliferation as the central gateway of an IATA for non-genotoxic carcinogenicity.

14 May 2014 in Mutagenesis
Verified
Journal Article
Open access
PDF file
SOSaeko Onami
Saeko Onami
YCYoung-Man Cho
Young-Man Cho
TTTakeshi Toyoda
Takeshi Toyoda
KHKatsuyoshi Horibata
Katsuyoshi Horibata
YIYuji Ishii
Yuji Ishii
KOKumiko Ogawa
Kumiko Ogawa
3-Monochloropropane-1,2-diol (3-MCPD) is regarded as a rat renal and testicular carcinogen and has been classified as a possible human carcinogen (group 2B) by International Agency for Research on Cancer. This is potentially of great importance given that esters of this compound have recently found to be generated in many foods and food ingredients as a result of food processing. There have been a few reports about their toxicity, although we have recently found that the toxicity profile of 3-MCPD esters was similar to that of 3-MCPD in a rat 13-week repeated dose study, except for the acute renal toxicity seen in 3-MCPD-treated females. In the present study, to examine in vivo genotoxicity we administered equimolar doses of 3-MCPD or 3-MCPD fatty acid esters (palmitate diester, palmitate monoester and oleate diester) to 6-week-old male F344 gpt delta rats carrying a reporter transgene for 4 weeks by intragastric administration. In vivo micronucleus, Pig-a mutation and gpt assays were performed, as well as investigations of major toxicological parameters including histopathological features. As one result, the relative kidney weights of the 3-MCPD and all three ester groups were significantly increased compared with the vehicle control group. However, the frequency of micronucleated reticulocytes and Pig-a mutant red blood cells did not differ among groups. Moreover, no changes were observed in mutant frequencies of gpt and red/gam (Spi−) genes in the kidney and the testis of 3-MCPD and 3-MCPD-fatty-acid-esters-treated rats. In histopathological analyses, no treatment related changes were observed, except for decrease of eosinophilic bodies in the kidneys of all treated groups. These results suggest that 3-MCPD and its fatty acid esters are not in vivo genotoxins, although they may exert renal toxicity.

1 December 2015 in Regulatory Toxicology and Pharmacology
Verified
Journal Article
Closed access
SOSaeko Onami
Saeko Onami
YCYoung-Man Cho
Young-Man Cho
TTTakeshi Toyoda
Takeshi Toyoda
JAJun-Ichi Akagi
Jun-Ichi Akagi
SFSatoshi Fujiwara
Satoshi Fujiwara
KOKumiko Ogawa
Kumiko Ogawa